王兴旭,张奇

• 1:同济大学附属东方医院心内科

摘要(Abstract)：

<正>激光血管成形术诞生于20世纪80年代,最初仅仅是用于治疗动脉粥样硬化造成的严重肢端缺血[1]。1992年美国食品药品监督管理局批准其用于冠状动脉的消融治疗。早期激光血管成形术治疗因围术期并发症多、安全性低等原因,临床使用率低。近年来,随着激光导管等器械及技术的进步,其操作安全性和手术成功率有了明显的提升,重新进入了临床医师的视野中。

关键词(KeyWords)： 准分子激光冠状动脉斑块消融术;经皮冠状动脉介入治疗;斑块修饰

Abstract:

Keywords:

基金项目(Foundation): 上海市浦东新区卫生系统重点学科群建设（PWZxq2017-05）;; 浦东新区学科带头人计划资助（PWRd2018-06）

作者(Author): 王兴旭,张奇

参考文献(References)：

• [1]Ginsburg R,Kim DS,Guthaner D,et al.Salvage of an ischemic limb by laser angioplasty:description of a new technique.Clin Cardiol,1984,7(1):54-58.
• [2]Egred M,Brilakis ES.Excimer laser coronary angioplasty(ELCA):fundamentals,mechanism of action,and clinical applications.J Invasive Cardiol,2020,32(2):E27-E35.
• [3]Nakabayashi K,Sunaga D,Kaneko N,et al.Simple percutaneous coronary interventions using the modification of complex coronary lesion with excimer laser.Cardiovasc Revasc Med,2019,20(4):293-302.
• [4]李琪，刘健，卢明瑜，等.准分子激光冠状动脉斑块消融术治疗复杂冠状动脉病变的近期临床效果观察.中国介入心脏病学杂志，2019,27(1):41-44.
• [5]李牧蔚，刘巍，赵康.准分子激光消融术在光学相干断层扫描技术指导下治疗冠状动脉旁路移植术后静脉桥血管狭窄病变.中国介入心脏病学杂志，2018,26(1):55-57.
• [6]Miyazaki T,Ashikaga T,Fukushima T,et al.Treatment of in-stent restenosis by excimer laser coronary atherectomy and drug-coated balloon:serial assessment with optical coherence tomography.J Interv Cardiol,2019,2019:6515129.
• [7]Lee T,Shlofmitz RA,Song L,et al.The effectiveness of excimer laser angioplasty to treat coronary in-stent restenosis with peri-stent calcium as assessed by optical coherence tomography.Euro Intervention,2019,15(3):e279-e288.
• [8]Shishikura D,Otsuji S,Takiuchi S,et al.Vaporizing thrombus with excimer laser before coronary stenting improves myocardial reperfusion in acute coronary syndrome.Circ J,2013,77(6):1445-1452.
• [9]Ebersole D,Dahm JB,Das T,et al.Excimer laser revascularization of saphenous vein grafts in acute myocardial infarction.J Invasive Cardiol,2004.16(4):177-180.
• [10]Bilodeau L,Fretz EB,Taeymans Y,et al.Novel use of a high-energy excimer laser catheter for calcified and complex coronary artery lesions.Catheter Cardiovasc Interv,2004,62(2):155-161.
• [11]Ambrosini V,Sorropago G,Laurenzano E,et al.Early outcome of high energy Laser (Excimer) facilitated coronary angioplasty ON h ARD and complex calcified and ballo Onresistant coronary lesions:LEONARDO Study.Cardiovasc Revasc Med,2015,16(3):141-146.
• [12]Badr S,Ben-Dor I,Dvir D,et al.The state of the excimer laser for coronary intervention in the drug-eluting stent era.Cardiovasc Revasc Med,2013,14(2):93-98.
• [13]Karacsonyi J,Karmpaliotis D,Alaswad K,et al.Prevalence,indications and management of balloon uncrossable chronic total occlusions:Insights from a contemporary multicenter USregistry.Catheter Cardiovasc Interv,2017,90(1):12-20.
• [14]Mohandes M,Rojas S,Moreno C,et al.Excimer laser in percutaneous coronary intervention of device uncrossable chronic total and functional occlusions.Cardiovasc Revasc Med,2020,21(5):657-660.
• [15]Egred M.RASER angioplasty.Catheter Cardiovasc Interv,2012,79(6):1009-1012.
• [16]Fernandez JP,Hobson AR,Mc Kenzie D,et al.Beyond the balloon:excimer coronary laser atherectomy used alone or in combination with rotational atherectomy in the treatment of chronic total occlusions,non-crossable and non-expansible coronary lesions.Euro Intervention,2013,9(2):243-250.
• [17]Sonoda S,Morino Y,Ako J,et al.Impact of final stent dimensions on long-term results following sirolimus-eluting stent implantation:serial intravascular ultrasound analysis from the sirius trial.J Am Coll Cardiol,2004,43(11):1959-1963.
• [18]Cheneau E,Leborgne L,Mintz GS,et al.Predictors of subacute stent thrombosis:results of a systematic intravascular ultrasound study.Circulation,2003,108(1):43-47.
• [19]Egred M.A novel approach for under-expanded stent:excimer laser in contrast medium.J Invasive Cardiol,2012,24(8):E161-E163.
• [20]Latib A,Takagi K,Chizzola G,et al.Excimer Laser LEsion modification to expand non-dilatable stents:the ELLEMENTregistry.Cardiovasc Revasc Med,2014,15(1):8-12.
• [21]Stefanini GG,Holmes Jr DR.Drug-eluting coronary-artery stents.N Engl J Med,2013,368(3):254-265.
• [22]Kokkinidis DG,Waldo SW,Armstrong EJ.Treatment of coronary artery in-stent restenosis.Expert Rev Cardiovasc Ther,2017,15(3):191-202.
• [23]Nishino M,Lee Y,Nakamura D,et al.Differences in optical coherence tomographic findings and clinical outcomes between excimer laser and cutting balloon angioplasty for focal in-stent restenosis lesions.J Invasive Cardiol,2012,24(10):478-483.
• [24]Hirose S,Ashikaga T,Hatano Y,et al.Treatment of in-stent restenosis with excimer laser coronary angioplasty:benefits over scoring balloon angioplasty alone.Lasers Med Sci,2016,31(8):1691-1696.
• [25]Ambrosini V,Golino L,Niccoli G,et al.The combined use of Drug-eluting balloon and Excimer laser for coronary artery Restenosis In-Stent Treatment:The DERIST study.Cardiovasc Revasc Med,2017,18(3):165-168.
• [26]Sato T,Tsuchida K,Yuasa S,et al.The effect of the debulking by excimer laser coronary angioplasty on long-term outcome compared with drug-coating balloon:insights from optical frequency domain imaging analysis.Lasers Med Sci,2020,35(2):403-412.
• [27]Dahm JB,Topaz O,Woenckhaus C,et al.Laser-facilitated thrombectomy:a new therapeutic option for treatment of thrombus-laden coronary lesions.Catheter Cardiovasc Interv,2002,56(3):365-372.
• [28]Topaz O,Bernardo NL,Shah R,et al.Effectiveness of excimer laser coronary angioplasty in acute myocardial infarction or in unstable angina pectoris.Am J Cardiol,2001,87(7):849-855.
• [29]Topaz O,Minisi AJ,Bernardo NL,et al.Alterations of platelet aggregation kinetics with ultraviolet laser emission:the"stunned platelet"phenomenon.Thromb Haemost,2001,86(4):1087-1093.
• [30]Topaz O,Ebersole D,Das T,et al.Excimer laser angioplasty in acute myocardial infarction (the CARMEL multicenter trial).Am J Cardiol,2004,93(6):694-701.
• [31]Nishino M,Mori N,Takiuchi S,et al.Indications and outcomes of excimer laser coronary atherectomy:Efficacy and safety for thrombotic lesions-The ULTRAMAN registry.JCardiol,2017,69(1):314-319.
• [32]Neumann FJ,Sousa-Uva M,Ahlsson A,et al.2018 ESC/EACTS Guidelines on myocardial revascularization.Eur Heart J,2019,40(2):87-165.
• [33]Niccoli G,Belloni F,Cosentino N,et al.Case-control registry of excimer laser coronary angioplasty versus distal protection devices in patients with acute coronary syndromes due to saphenous vein graft disease.Am J Cardiol,2013,112(10):1586-1591.